Clinical Trial for GNX80 in Intermittent Claudication
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT05400395
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT05400395
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT05400395. Randomized; quadruple masking; primary purpose treatment. Start 2022-09-05 (actual); primary completion 2024-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial for GNX80 in Intermittent Claudication
- Condition
- Intermittent Claudication
- Intervention (Drug)
- GNX80
- Intervention (Drug)
- Placebo
- Lead sponsor
- SK Chemicals Co., Ltd.
Record details
- Record id
cardio:ct-nct05400395- Content hash
5c964a63b890b9cc7e003d4f4c9f2d346ea5ff7008fd584d9afe974bc1684563